RIDGEFIELD, Conn. & NEW YORK----Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved SPIRIVA® HandiHaler® for the reduction of exacerbations in patients with chronic obstructive pulmonary disease .
No comments:
Post a Comment